Merck KGaA : Demonstrates Commitment to Corporate Responsibility

Contact

 2014 Corporate Responsibility Report published for the first time in accordance with the comprehensive option of the Global Reporting Initiative (GRI) G4 guidelines

 Sustainability strategy comprises health, the environment and culture as strategic spheres of activity

Darmstadt, April 20, 2015 - Merck, a leading company for innovative, top-quality high- tech products in healthcare, life science and performance materials, made significant progress in achieving its corporate responsibility objectives in 2014. The Corporate Responsibility Report for 2014 documents Merck's ecological and social performance. Numerous examples demonstrate how sustainability is contributing to long-term entrepreneurial success and show how the company is meeting current and future challenges, such as access to health and climate change.
"We at Merck have been taking responsibility since the company was founded nearly
350 years ago. That is because we are convinced that success can only be sustainable if it is achieved responsibly. In order to live up to our responsibility even more effectively, last year we defined three strategic spheres of activity: health, the environment and culture," said Stefan Oschmann, Vice Chairman of the Executive Board.
In its Group-wide corporate responsibility efforts, Merck places emphasis on climate protection and energy efficiency. By 2020, Merck intends to reduce its total global greenhouse gas emissions by 20% (measured against the 2006 baseline). In 2014,

Merck KGaA

Frankfurter Strass 250 Head of Media Relations -62445

64293 Darmstadt Spokesperson: -9591 / -7144 / -6328

Hotline +49 6151 72-5000 Fax +49 6151 72-3138 www.merckgroup.commedia.relations@merckgroup.com

Page 1 of 3

Merck lowered its greenhouse gas emissions by around 8% despite growth in its operating business. Spending on environmental protection, health and safety amounted to € 146 million, which was € 4 million more than in 2013.
In addition, Merck undertakes numerous activities to help underserved populations and patients in low- and middle-income countries gain access to health solutions. An im- portant project is the Merck Praziquantel Donation Program. Merck has committed it- self to eliminating the tropical disease schistosomiasis in Africa in collaboration with the World Health Organization (WHO). In 2014, Merck produced more than 75 million pra- ziquantel tablets. As of the end of 2014, the company had supplied more than 72 mil- lion tablets to the recipient countries in Africa in coordination with WHO, representing an increase of 44% over 2013.
Merck has also made good progress with respect to workforce diversity. In 2011, Merck had set itself the goal of increasing the proportion of female executives Group-wide to between 25% and 30% by 2016. In 2014, the proportion was 26%.
Merck's renewed inclusion in the FTSE4Good Index, the leading international corporate responsibility index, underscores the fact that the company performs well in complying with global corporate responsibility standards. Merck shares are additionally included in the following sustainability indices: STOXX Global ESG Leaders, the Euronext Vigeo Eurozone 120-Index, the Ethibel EXCELLENCE Investment Register, and the Ethibel Sustainability Index Excellence Europe.
Merck has prepared its Corporate Responsibility Report for 2014 for the first time in accordance with the comprehensive option of the Global Reporting Initiative (GRI) G4 guidelines. The online report is available in German and English on the Merck website.

Page 2 of 3

• Interactive online Corporate Responsibility Report 2014optimized for mobile devices
• Merck on Facebook, Twitterand LinkedIn
• Merck photos and video footage can be found here

All Merck news releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribeto register online, change your selection or discontinue this service.

Merck is a leading company for innovative, top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses - Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials - and generated sales of around €

11.3 billion in 2014. Around 39,000 employees work for Merck in 66 countries to improve the quality of life for patients, to further the success of customers, and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation,

business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials.

Page 3 of 3

distributed by